School of Medicine


Showing 1-15 of 15 Results

  • Peter Johannes van Roessel

    Peter Johannes van Roessel

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Bio Dr Peter van Roessel, M.D. Ph.D, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University, where he provided clinical care for individuals participating in research studies across a spectrum of psychiatric illness, including treatment resistant mood disorders, anxiety disorders, psychosis and substance use disorders.

    At Stanford, he sees adult mood and anxiety disorders outpatients through the Evaluations Clinic and Depression Clinic and participates in resident training and patient care as a supervisor in psychodynamic psychotherapy and as an attending physician in Continuity Clinic. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment, and contributes to clinical neuroscience studies pioneering rapid-acting interventions in OCD.

    Dr van Roessel pursued research training basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology in the laboratory of Dr Andrea Brand at the University of Cambridge, UK. More recently, he has contributed to work in the lab of Dr Julia Kaltschmidt (Sloan Kettering Institute, now Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. In the Rodriguez Lab, he is pursuing clinically-motivated research interests related to the nature and neural correlates of insight in obsessive-compulsive and related disorders. He has additionally received a 2018 NARSAD Young Investigator Award to pursue a novel glutamatergic rapid-acting treatment for OCD.

  • Andrea Varias

    Andrea Varias

    Casual - Non-Exempt, Psych/Public Mental Health & Population Sciences

    Current Role at Stanford Serving member on the Lab?s Leadership Executive Team as lead clinical research coordinator for studies involving individuals with obsessive-compulsive disorder (OCD) and anxiety-related disorders (including Hoarding Disorder and Post-Traumatic Stress Disorder)

    ? Conversant in goals, mission and priorities of the Lab and University as primary contact for sponsors, regulatory agencies, Clinical Trials Research Unit, and study participants.
    ? Demonstrates a high degree of professionalism, initiative and flexibility while managing and auditing all aspects of clinical trials, including development, study start-up, implementation, compliance, and closure of IRB- and FDA-regulated studies.
    ? Leads a 10-person team of research coordinators and undergraduate assistants focused on research projections/goals, protocol management, and adverse event reporting.

  • Nina Vasan, MD, MBA

    Nina Vasan, MD, MBA

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Mental illness is the greatest thief of human potential today. By harnessing the power of medicine, entrepreneurship, and technology, we can return that potential to the 2 billion people suffering around the world.

    Brainstorm is the world's first academic laboratory dedicated to transforming mental health through innovation and entrepreneurship.

  • Pablo Villoslada

    Pablo Villoslada

    Adjunct Professor, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator

    Bio Pablo Villoslada received his MD at the University of Santiago de Compostela (Spain) in 1990. He completed the speciality in neurology in 1995 at the Hospital Vall d?Hebron (Spain) and the PhD in Neuroimmunology in 1996 at the Autonomous University of Barcelona (Spain). He moved to the University of California, San Francisco (US) as a postdoctoral fellow returning to Barcelona in 1998 and he worked as Assistant Professor of the University of Navarra from 2001 to 2008. He became Group leader of the Neuroimmunology group of the Institute of Biomedical Research August Pi Sunyer (IDIBAPS) ? Hospital Clinic - University of Barcelona, Spain, in 2009. From 2014 to 2017 he became Adjunct Professor at the Department of Neurology at the University of California, San Francisco. From 2017 to 2018 he worked a Medical Director of Neuroinflammation at Genentech. Since October 2018 is adjunct professor at Stanford University. He is a serial entrepreneur, having founded Health Engineering (imaging software) and Bionure (drug development CNS), and being venture partner with Alta Life Sciences and Spire Bioventure. He joined the neurosciences team at Stanford University in October 2018.

    Pablo Villoslada has been active in the Neurosciences and brain diseases research for more than 20 years contributing to the application of systems biology to neurological diseases, development of new therapies or biomarkers for Multiple Sclerosis and neurodegenerative diseases, and developing new neuroimaging technologies for monitoring brain diseases. He has published more than 170 scientific articles in journals in the field of neurology and has been granted 9 patents in biomarkers and new therapies for brain diseases. He has also obtained 5 EU grants and several others from international foundations.

  • Louis Vismara

    Louis Vismara

    Adjunct Professor, Psych/Interdisciplinary Brain Sciences

    Bio Dr. Vismara is a physician (retired interventional cardiologist) and a parent of four children. Since his son, Mark, was diagnosed with autism in 1995, he has dedicated himself to issues of child development, learning differences, diversity, and access to health care for under-served populations. Lou is a founding member of the UC Davis MIND Institute, the State of California's First Five Commission, and the California Legislative Blue Ribbon Commission on Autism.
    From 2000 to 2015, Lou worked as one of the most senior staff members in the Legislature as a senior policy consultant for three consecutive leaders (Senators Burton, Perata, & Steinberg) of the California Senate. In 2009 Lou established the Senate Select Committee on Autism & Related Disorders. The Committee, which was chaired by Senate President Darrell Steinberg, provided the impetus for 51 separate legislative measure, 26 of which were signed into law.
    Dr. Vismara is currently serving as a consultant for AKT Investments, which with the UC Davis Health Systems, is seeking to establish an integrated, health-focused community for individuals of all abilities across the lifespan. Lou has also been retained by the CA Community College Chancellor?s Office to establish an innovative employment/vocational training program for neurodiverse students, which will provide services and supports for older adults.

Footer Links:

Stanford Medicine Resources: